for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Markets News

BRIEF-Inmed Pharmaceuticals Reports Q3 Loss Per Share Of C$0.01

May 11 (Reuters) - InMed Pharmaceuticals Inc:

* INMED REPORTS THIRD QUARTER FISCAL 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

* Q3 LOSS PER SHARE C$0.01

* INMED PHARMACEUTICALS - AT MARCH 31, 2018, CO’S CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS WERE $13.88 MILLION, VERSUS $6.71 MILLION AT JUNE 30, 2017 Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up